The Scottish Government have published their annual summary of prescribing statistics for mental health drugs. The report shows increases in the prescribing rates for all groups of drugs over the last 12 months. The prescribing costs of some groups of drugs have also risen (ADHD, dementia, depression) although other groups have seen a decline (insomnia [read the full story…]
Some of the older elves in the woodland don’t join in with our social activities as much as they used to. The younger elves call them ‘cranky’ and laugh at them sitting alone in their tree houses. Personally I worry that they might be feeling lonely and I doubt that shutting themselves away from the [read the full story…]
I really enjoyed the discussion in the Guardian over the weekend about poor quality trials and pharmaceutical industry techniques that overhype their drugs in an attempt to shift units. Ben Goldacre’s new Bad Pharma book is well worth a read. New reviews about antidepressants come thick and fast and it’s often hard to know what [read the full story…]
Women who experience intimate partner abuse (IPA) often suffer from mental health problems as a result. Post-traumatic stress disorder (PTSD), depression and fear of further attacks are all common and understandable responses. Despite this, there are not many longitudinal studies that follow a group of women over a period of time and assess what interventions [read the full story…]
To date, ecstasy use has been very much associated with young people and clubbing, but some research has shown that the environments in which it is taken is now beginning to broaden. Lifetime prevalence rates for the drug are around 10% in the US and 8.6% in the UK according to 2010 EMCDDA estimates. The [read the full story…]
In these times of austerity, there is a lot of interest in computerised cognitive behavioural therapy (cCBT) as a treatment for people with depression and anxiety. It is hoped that this cheap and easy to deliver intervention can help to reduce the long waiting lists for face-to-face talking treatments. I’ve regularly blogged about cCBT over [read the full story…]
Published yesterday in the Lancet, the Multicentre Study of Self-harm in England is a large (30,950 patients) cohort study of people presenting to hospital emergency departments in Oxford, Manchester and Derby, with self-poisoning or self-injury during 2000-2007. We know that people who self-harm have an increased risk of dying early, but this study tries to [read the full story…]
The Government has published its response to the House of Commons Health Select Committee inquiry on the Government’s Alcohol Strategy. The Committee gave a positive welcome overall to the Government’s Alcohol Strategy and it welcomed the decision to introduce a minimum unit price for alcohol. The 4 key recommendations from the report are: The Committee [read the full story…]
Early diagnosis and effective treatment of dementia will help large numbers of the population remain independent for longer. Cholinesterase inhibitors are one of the anti-dementia drugs that are used to treat Alzheimer’s disease, and they are often used immediately after diagnosis. This new systematic review from the Cochrane Dementia and Cognitive Improvement Group, looks at [read the full story…]
This new briefing paper from the NHS Confederation and the Centre for Mental Health looks at the impact that personalisation and recovery are having on mental health services in England. The first part of this paper describes personalisation, personal budgets and personal health budgets. The second sets out their shared philosophy and discusses what the [read the full story…]
